166 related articles for article (PubMed ID: 1898737)
21. Purification and characterization of natural and recombinant human plasminogen activator inhibitor-1 (PAI-1).
Alessi MC; Declerck PJ; De Mol M; Nelles L; Collen D
Eur J Biochem; 1988 Aug; 175(3):531-40. PubMed ID: 3261688
[TBL] [Abstract][Full Text] [Related]
22. The interaction of recombinant tissue type plasminogen activator and recombinant plasminogen activator (r-PA/BM 06.022) with human endothelial cells.
Mulder M; Kohnert U; Fischer S; van Hinsbergh VW; Verheijen JH
Blood Coagul Fibrinolysis; 1997 Mar; 8(2):124-33. PubMed ID: 9518044
[TBL] [Abstract][Full Text] [Related]
23. Type 1 plasminogen activator inhibitor synthesis of endothelial cells is downregulated by smooth muscle cells.
Christ G; Seiffert D; Hufnagl P; Gessl A; Wojta J; Binder BR
Blood; 1993 Mar; 81(5):1277-83. PubMed ID: 8443389
[TBL] [Abstract][Full Text] [Related]
24. Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo.
Quax PH; van den Hoogen CM; Verheijen JH; Padro T; Zeheb R; Gelehrter TD; van Berkel TJ; Kuiper J; Emeis JJ
J Biol Chem; 1990 Sep; 265(26):15560-3. PubMed ID: 2118527
[TBL] [Abstract][Full Text] [Related]
25. Thrombin regulates components of the fibrinolytic system in human mesangial cells.
Villamediana LM; Rondeau E; He CJ; Medcalf RL; Peraldi MN; Lacave R; Delarue F; Sraer JD
Kidney Int; 1990 Nov; 38(5):956-61. PubMed ID: 2125090
[TBL] [Abstract][Full Text] [Related]
26. Glucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2.
Medcalf RL; Van den Berg E; Schleuning WD
J Cell Biol; 1988 Mar; 106(3):971-8. PubMed ID: 3126194
[TBL] [Abstract][Full Text] [Related]
27. Plasmin and the regulation of tissue-type plasminogen activator biosynthesis in human endothelial cells.
Shi GY; Hau JS; Wang SJ; Wu IS; Chang BI; Lin MT; Chow YH; Chang WC; Wing LY; Jen CJ
J Biol Chem; 1992 Sep; 267(27):19363-8. PubMed ID: 1388168
[TBL] [Abstract][Full Text] [Related]
28. Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor.
Schleef RR; Bevilacqua MP; Sawdey M; Gimbrone MA; Loskutoff DJ
J Biol Chem; 1988 Apr; 263(12):5797-803. PubMed ID: 3128548
[TBL] [Abstract][Full Text] [Related]
29. Structural requirements for the extracellular interaction of plasminogen activator inhibitor 1 with endothelial cell matrix-associated vitronectin.
Preissner KT; Grulich-Henn J; Ehrlich HJ; Declerck P; Justus C; Collen D; Pannekoek H; Müller-Berghaus G
J Biol Chem; 1990 Oct; 265(30):18490-8. PubMed ID: 1698787
[TBL] [Abstract][Full Text] [Related]
30. Effect of notoginsenoside R1 on the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in cultured human umbilical vein endothelial cells.
Zhang W; Wojta J; Binder BR
Arterioscler Thromb; 1994 Jul; 14(7):1040-6. PubMed ID: 8018658
[TBL] [Abstract][Full Text] [Related]
31. Regulation of the fibrinolytic potential of cultured human umbilical vein endothelial cells: astragaloside IV downregulates plasminogen activator inhibitor-1 and upregulates tissue-type plasminogen activator expression.
Zhang WJ; Wojta J; Binder BR
J Vasc Res; 1997; 34(4):273-80. PubMed ID: 9256087
[TBL] [Abstract][Full Text] [Related]
32. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells.
Pepper MS; Ferrara N; Orci L; Montesano R
Biochem Biophys Res Commun; 1991 Dec; 181(2):902-6. PubMed ID: 1755866
[TBL] [Abstract][Full Text] [Related]
33. Effects of fibrin on the secretion of plasminogen activator inhibitor-1 from endothelial cells and on protein kinase C.
Fukao H; Matsumoto H; Ueshima S; Okada K; Matsuo O
Life Sci; 1995; 57(13):1267-76. PubMed ID: 7674818
[TBL] [Abstract][Full Text] [Related]
34. Stimulation by retinoids of tissue-type plasminogen activator secretion in cultured human endothelial cells: relations of structure to effect.
Bulens F; Nelles L; Van den Panhuyzen N; Collen D
J Cardiovasc Pharmacol; 1992 Apr; 19(4):508-14. PubMed ID: 1380592
[TBL] [Abstract][Full Text] [Related]
35. Tissue-type plasminogen activator binding to human endothelial cells. Evidence for two distinct binding sites.
Barnathan ES; Kuo A; Van der Keyl H; McCrae KR; Larsen GR; Cines DB
J Biol Chem; 1988 Jun; 263(16):7792-9. PubMed ID: 3131327
[TBL] [Abstract][Full Text] [Related]
36. Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation.
Quax PH; van Muijen GN; Weening-Verhoeff EJ; Lund LR; Danø K; Ruiter DJ; Verheijen JH
J Cell Biol; 1991 Oct; 115(1):191-9. PubMed ID: 1918136
[TBL] [Abstract][Full Text] [Related]
37. Molecular forms of plasminogen activator inhibitor-1 (PAI-1) and tissue-type plasminogen activator (t-PA) in human plasma.
Alessi MC; Juhan-Vague I; Declerck PJ; Collen D
Thromb Res; 1991 May; 62(4):275-85. PubMed ID: 1907771
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of endothelial secretion of tissue-type plasminogen activator and its rapid inhibitor by agents which increase intracellular cyclic AMP.
Francis RB; Neely S
Biochim Biophys Acta; 1989 Jul; 1012(2):207-13. PubMed ID: 2545266
[TBL] [Abstract][Full Text] [Related]
39. Carbazochrome sodium sulphonate (AC-17) decreases the accumulation of tissue-type plasminogen activator in culture medium of human umbilical vein endothelial cells.
Matsumoto Y; Hayashi T; Hayakawa Y; Shinbo M; Niiya K; Sakuragawa N
Blood Coagul Fibrinolysis; 1995 May; 6(3):233-8. PubMed ID: 7654937
[TBL] [Abstract][Full Text] [Related]
40. Expression of PAI-1, t-PA and u-PA in cultured human umbilical vein endothelial cells derived from racial groups.
Frist ST; Taylor HA; Kirk KA; Grammer JR; Li XN; Grenett HE; Booyse FM
Thromb Res; 1995 Feb; 77(3):279-90. PubMed ID: 7740520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
